ЛАПАРОСКОПИЧЕСКАЯ ТОТАЛЬНАЯ МЕЗОРЕКТУМЭКТОМИЯ (обзор литературы)

рак прямой кишки, тотальная мезоректумэктомия, качество препарата ТМЭ, трансанальная ТМЭ

1. Glimelius B., Tiret E., Cervantes A. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. -2013; 24 (6): 81-8.

2. Monson J.R., Weiser M.R., Buie W.D. et al. Practice parameters for the management of rectal cancer (revised). Dis. Colon Rectum. - 2013; 56 (5): 535-50.

3. Heald R.J., Husband E.M., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. - 1986; 1: 1479-1482.

4. Jonnesco T. Appareil digestif. In: Poirier P, Charpy A, eds. Traite d’anatomie Humaine. Vol. IV. 2nd ed. Paris: Masson et Cie. - 1901: 372-373.

5. Gerota D. Die lymphgefasse des rectums und des anus. Archive fur Anatomie und Physiologie. Anatomische Abtheilung. - 1895: 240-256.

6. Waldeyer W. Das Becken. Bohn: Cohen. - 1899.

7. Chapuis P., Bokey L., Fahrer M. et al. Mobilization of the rectum: anatomic concepts and the bookshelf revisited. Dis. Colon Rectum. - 2002; 45: 1-9.

8. Heald R.J., Husband E.M., Ryall R.O. The mesorectum in rectal surgery: the clue to pelvic recurrence? Br. J. Surg. - 1982; 69: 613-616.

9. Abel A.L. The modern treatment of cancer of the rectum. Milwaukee Proc. - March 3-5, 1931: 296-300.

10. Heald R.J. A new approach to rectal cancer. Br. J. Hosp. Med. - 1979; 22: 277-281.

11. Martling A.L., Holm T., Rutqvist L.E. et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group. Basingstoke Bowel Cancer Research Project. Lancet. - 2000; 356: 93-96.

12. MacFarlane J.K., Ryall R.D., Heald R.J. Mesorectal excision for rectal cancer. Lancet. - 1993; 341: 457-460.

13. Enker W.E., Thaler H.T., Cranor M.L. et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J. Am. Coll Surg. - 1995; 181: 335-346.

14. Moriya Y., Sugihara K., Akasu T. et al. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J. Surg. - 1997; 21: 728-732.

15. Heald R.J., Moran B.J., Ryall R.D. et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch. Surg. - 133 (8): 894-899.

16. Kapiteijn E., Marijnen C.A., Nagtegaal I.D. et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. - 2001; 345: 638-646.

17. Wibe A., Eriksen M.T., Syse A. et al. Total mesorectal excision for rectal cancer - what can be achieved by a national audit? Colorectal Dis. - 2003; 5: 471-477. _

18. Campa-Thompson M., Weir R., Calcetera N. et al. Pathologic processing of the total mesorectal excision. Clinics in colon and rectal surgery. - 2015; 28: 43-52.

19. Kusters M., Marijnen C.A., van de Velde C.J. et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. - 2010. EJSO 36: 470-476.

20. Maslekar S., Sharma A., Macdonald A. et al. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis. Colon Rectum. - 2007; 50: 168-175.

21. Nagtegaal I.D., van de Velde C.J., van der Worp E. et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. - JCO 2002; 20: 1729-1734.

22. Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet. - 2003; 4: 695-702.

23. Quirke P., Durdey P., Dixon M.F. et al. Local recurrence ofrectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. - 1986; 2: 996-999.

24. Simunovic M.R., DeNardi F.G., Coates A.J. et al. Product analysis and initial reliability testing of the total mesorectal excision-quality assessment instrument. Ann. Surg. Oncol. - 2014; 21: 2274-2279.

25. Beattie G.C., McAdam T.K., Elliott S. et al. Improvement in quality of colorectal cancer pathology reporting with a standardized proforma -a comparative study. Colorectal disease. - 2003; 5: 558-562.

26. Quirke P., Morris E. Reporting colorectal cancer. Histopathology. - 2007; 50: 103-112.

27. Hyuk Baik S., Kyu Kim N., Young Lee K. et al. Factors Influencing Pathologic Results after Total Mesorectal Excision for Rectal Cancer: Analysis of Consecutive 100 Cases. Ann. Surg. Oncol. - 2007, 5: 5.

28. Stewart D.B., Dietz D.W. Total mesorectal excision: What are we doing? Clin. Colon Rectal. Surg. - 2007; 20 (3): 190-202.

29. Havenga K., Grossmann I., DeRuiter M. et al. Definition of total mesorectal excision, including the perineal phase: technical considerations. Digestive diseases. - 2007; 25: 44-50.

30. Phang P.T. Total mesorectal excision: technical aspects. Can. J. Surg. - 2004; 47 (2): 130-137.

31. Jeyarajah S., Sutton C.D., Miller A.S. et al. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal disease. - 2007; 9: 808-815.

32. Deng H., Chen H., Zhao L. Quality of laparoscopic total mesorectal excision: results from a single institution in China. Hepatogastroenterology. - 2015; 62: 264-267.

33. Leonard D., Penninckx F., Fieuws S. et al. PROCARE, a multidisciplinary Belgian Project on Cancer of the Rectum. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann. Surg. - 2010; 252 (6): 982-988. КОЛОПРОКТОЛОГИЯ, 2016, № 4 (58)

34. Sebag-Montefiore D., Stephens R.J., Steele R. et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. - 2009; 373 (9666): 811-20.

35. Bosch S.L., Nagtegaal I.D. The importance of the pathologist's role in assessment of the quality of the mesorectum, Curr. Colorectal Cancer Rep. - 2012; 8 (2): 90-98.

36. Mendez M.A., Wilcox R., Callas P.W. et al. Tumor Location may Affect Total Mesorectal Excision Quality. Colorectal Cancer: Open Access. - 2016; Vol. 2 No. 1 (12): 1-6.

37. Lacy A.M., Garcia-Valdecasas J.C., Delgado S. et al. Laparoscopy- assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. - 2002; 359: 2224-2229.

38. Leung K.L., Kwok S.P., Lam S.C. et al. Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet. - 2004; 363: 1187-1192.

39. Wu W.X., Sun Y.M., Hua Y.B. et al. Laparoscopic versus conventional open resection ofrectal carcinoma: a clinical comparative study. World J. Gastroenterol. -2004; 10: 1167-1170.

40. Quirke P., Steele R., Monson J. et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. - 2009; 373 (9666): 821-8.

41. Laurent C., Leblanc F., Wutrich P. et al. Laparoscopic versus open surgery for rectal cancer: long-term oncologic re sults. Ann. Surg. - 2009; 250: 54-61.

42. Vennix S., Pelzers L., Bouvy N. et al. Laparoscopic versus open total mesorectal excision for rectal cancer. The Cochrane database of systematic reviews 4: Cd005200.

43. Baik S.H., Kim N.K., Lim D.R. et al. Oncologic outcomes and perioperative clinicopathologic results after robot-assisted tumor-specific mesorectal excision for rectal cancer. Ann. Surg. Oncol. - 2013; 20: 2625-2632.

44. Pucci M.J., Beekley A.C. Use of robotics in colon and rectal surgery. Clin. Colon Rectal Surg. - 2013; 26: 39-46.

45. Heald R.J. A new solution to some old problems: transanal TME. Tech. Coloproctol. - 2013; 17: 257-258.

46. Leroy J., Barry B.D., Melani A. et al. No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery. JAMA Surg. -2013; 148: 226-230.

47. Lacy A.M., Adelsdorfer C., Delgado S. et al. Minilaparoscopy-assisted transrectal low anterior resection (LAR): a preliminary study. Surg. Endosc. -2013; 27: 339-346.

48. Atallah S., Nassif G., Polavarapu H. et al. Robotic-assisted transanal surgery for total mesorectal excision (RATS-TME): a description of a novel surgical approach with video demonstration. Tech. Coloproctol. - 2013; 17: 441-447.

49. Atallah S., Martin-Perez B., Albert M. Transanal minimally invasive surgery for totalmesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech. Coloproctol. -2013; 13; 1095-1097.

50. Velthuis S., Nieuwenhuis D.H., Ruijter T.E., et al. Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surg. Endosc. - 2014; 28 (12): 3494-9.

51. Veltcamp H.M., Deijen C.L., Velthuis S. et al. Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases. Surg. Endosc. - 2016; 30 (2): 464-70.

52. Perdawood S.K., Al Khefagie. Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark. Colorectal Dis. - 2016; 18 (1); 51-58.